# Amlodipine + Valsartan

## Exforge 5/80mg

| 藥物代碼           | OEXF                                                                                                                                                                                                                                                                                                              |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Hypertension                                                                                                                                                                                                                                                                                                      |
| 副作用             | common■Cardiovascular: Peripheral edema (5.4% )■Neurologic: Dizziness (2.1% )■Respiratory: Nasopharyngitis (4.3% ), Upper respiratory infection (2.9% )seriousCardiovascular: Hypotension (0.4% )                                                                                                                 |
| 禁忌               | ■Severe hepatic impairment, biliary cirrhosis or cholestasis. Severe renal impairment (GFR <30 mL/min/1.73 m2) & dialysis patients. Pregnancy.■hypersensitivity to amlodipine, valsartan, or any other component ■concomitant aliskiren use in diabetic patients                                                  |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                              |
| 用法用量           | 1 tab daily. ■hepatic impairment: amlodipine 2.5 mg should be the initial dose ■geriatric (75 years or older): amlodipine 2.5 mg should be the initial dose ■geriatric: increased exposure to amlodipine; consider a lower initial dose ■renal impairment: CrCl 30 mL/min or greater, no dose adjustment required |
| 肝功能異常         | 需 調 整 劑 量  肝功能不全及膽道阻塞患者使用時應謹慎小心,可考慮從最低可取得之Amlodipine劑量開始治療                                                                                                                                                                                                               |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                      |
| 懷孕用藥危分級     | 儘量避免                                                                                                                                                                                                                                                                                                          |
| 孕期用藥建議       | Human data suggest risk in 2nd and 3rd trimester                                                                                                                                                                                                                                                                  |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                               |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                               |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                               |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                               |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                               |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                               |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                               |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                               |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                               |

